Showing 2201-2210 of 3870 results for "".
- Allergan Aesthetics Submits BLA for TrenibotulinumtoxinE for Glabellar Lineshttps://modernaesthetics.com/news/abbvie-submits-bla-for-trenibotulinumtoxine-for-glabellar-lines/2475351/Allergan Aesthetics, an AbbVie Company, has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE), seeking approval for the treatment of moderate to severe glabellar lines. TrenibotE, a serotype E botulinum to
- Clinical Data on Lumenis’ New Laser Hair Removal Solution to Be Presented at ASLMS Conferencehttps://modernaesthetics.com/news/new-data-on-lumenis-new-laser-hair-removal-solution-to-be-presented-at-aslms-conference/2475349/Lumenis Be. Ltd. unveiled the newest edition of its breakthrough dual-wavelength laser hair removal solution, SPLENDOR XTM ahead of the American Society for Laser Medicine and Surgery (ASLMS) Conference. SPLENDOR XTM is powered by Lumenis’ proprietary BLEND X
- Bliss Aesthetics Raises $17.5M to Launch AI-Powered Cosmetic Surgery Platformhttps://modernaesthetics.com/news/bliss-aesthetics-raises-175m-to-launch-ai-powered-cosmetic-surgery-platform/2475345/Bliss Aesthetics, a digital platform that uses artificial intelligence (AI) to connect patients with board-certified plastic surgeons, announced a $17.5 million seed funding round. The investment, led by Shine Capital with participation from Synchrony Ventures, Sheva Ventures, Point72 Ventures, a
- SkinCare Physicians, Inc Launches New Cosmeceutical Testing Programhttps://modernaesthetics.com/news/skincare-physicians-inc-launches-new-cosmeceutical-testing-program/2473766/SkinCare Physicians’ dermatologists are launching a new testing program to provide cosmeceutical brands with the clinical validation their products need to earn consumer trust and industry recognition, the company announced on social media. “With rigorous testing that
- ASDSA Raises Patient Safety Concerns After Study Finds Lack of Physician Oversight in Missouri Med Spashttps://modernaesthetics.com/news/asdsa-raises-patient-safety-concerns-after-study-finds-lack-of-physician-oversight-in-missouri-med-spas/2473761/A study published in a recent issue of Dermatologic Surgery reveals a concerning lack of physician supervision and discrepancies in the level of training among those performing cosmetic medical procedures in Missouri medical spas. The study findings highlight the need for regulatory over
- 2025 AAD: Drs. Shino Bay Aguilera, Michael Somenek Face Off Over Filler Treatmentshttps://modernaesthetics.com/news/2025-aad-drs-shino-bay-aguilera-michael-somenek-face-off-over-filler-treatments/2473759/A ticketed session at the 2025 American Academy of Dermatology (AAD) Annual Meeting brought together leading experts in the field to debate some of the hottest injectable controversies from an evidence-based perspective, helping attendees choose the most appropriate treatments and achieve natural
- 2025 AAD: Treating Hyperpigmented and Hypertrophic Scars with Microneedling in Skin of Colorhttps://modernaesthetics.com/news/2025-aad-treating-hyperpigmented-and-hypertrophic-scars-with-microneedling-in-skin-of-color/2473758/Robyn Siperstein, MD, FAAD, presented “Use of Microneedling in Skin of Color: Treating Hyperpigmented and Hypertrophic Scars” at the 2025 American Academy of Dermatology Annual Meeting Sunday. “The key to this treatment and how I’ve really changed my anti-a
- New Solution to Alleviate Challenges from Denied Insurance Claims Unveiledhttps://modernaesthetics.com/news/new-solution-to-alleviate-challenges-from-denied-insurance-claims-unveiled-1/2473757/A new solution to alleviate the challenges posed by insurance claim denials and make it easier for providers to salvage denied claims and increase their reimbursement was on display at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, as Nextech previewed the late
- FDA Approves South Korean Neurotoxin for Frown Lineshttps://modernaesthetics.com/news/fda-approves-south-korean-neurotoxin-for-frown-lines/2473751/The US Food and Drug Administration approved the neurotoxin, Letybo (letibotulinumtoxinA-wlbg), to treat moderate-to-severe glabellar lines in adults, Hugel Inc. announced last week. According to a press release, Hugel Inc. plans to accelerate its transition for approved medical u
- Aesthetic Treatments Becoming More Popular Among Men, AAFPRS Data Showshttps://modernaesthetics.com/news/aesthetic-treatments-becoming-more-popular-among-men-aafprs-data-shows/2473744/While most patients for aesthetic treatments and procedures are women, men are beginning to embrace the industry, according to new data from the American Academy of Facial Plastic and Reconstructive Surgery. Men continue to surpass women when it comes to hair transplantation. Amon